Back to Alzheimers Disease
This trial is complete. It is no longer accepting participants.

NCT00000176

NCT00000176
Completed Phase 3

Who may be able to join

Who might be able to join this trial:

  • You are a woman aged 65 or older who is generally in good health
  • You have a family history of memory problems
  • You are not currently taking estrogen

Who may not be able to join:

  • You have significant problems with brain or nervous system function (confirm with trial site)
  • You are currently using estrogen
  • You have a history of breast cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 3
Sponsor
National Institute on Aging (NIA)
Registry
clinicaltrials_gov
Est. completion
1 September 2007

Where this trial is recruiting

🇺🇸 United States

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov